IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $15,232,000 | -22.5% | 179,141 | -67.7% | 0.52% | -27.2% |
Q2 2020 | $19,647,000 | +180.1% | 554,372 | +6.5% | 0.71% | +87.8% |
Q1 2020 | $7,014,000 | -23.0% | 520,297 | +20.8% | 0.38% | -9.8% |
Q4 2019 | $9,111,000 | +28.1% | 430,591 | -19.7% | 0.42% | +7.2% |
Q3 2019 | $7,111,000 | +4.5% | 536,288 | +9.3% | 0.39% | +16.4% |
Q2 2019 | $6,803,000 | +7.9% | 490,501 | +49.5% | 0.34% | -0.6% |
Q1 2019 | $6,304,000 | +22.4% | 328,161 | -9.1% | 0.34% | -7.4% |
Q4 2018 | $5,150,000 | -33.0% | 360,871 | -2.2% | 0.36% | -12.5% |
Q3 2018 | $7,687,000 | -8.8% | 369,021 | +3.7% | 0.42% | -17.9% |
Q2 2018 | $8,425,000 | +313.4% | 355,921 | +155.1% | 0.51% | +245.6% |
Q1 2018 | $2,038,000 | -9.6% | 139,500 | 0.0% | 0.15% | -16.9% |
Q4 2017 | $2,254,000 | – | 139,500 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,850,000 | $12,513,000 | 4.70% |
Avoro Capital Advisors LLC | 7,344,177 | $23,869,000 | 4.19% |
NEXTHERA CAPITAL LP | 1,263,276 | $4,106,000 | 2.52% |
Opaleye Management Inc. | 1,200,000 | $3,900,000 | 2.04% |
First Light Asset Management, LLC | 992,867 | $3,227,000 | 1.39% |
DAFNA Capital Management LLC | 566,796 | $1,842,000 | 1.28% |
Ghost Tree Capital, LLC | 2,000,000 | $6,500,000 | 1.05% |
Iguana Healthcare Management, LLC | 600,000 | $1,950,000 | 0.35% |
PURA VIDA INVESTMENTS, LLC | 319,565 | $1,039,000 | 0.32% |
J. Goldman & Co LP | 1,696,699 | $5,514,000 | 0.31% |